共 30 条
[1]
Angus D(2001)Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 1303-10
[2]
Linde-Zwirble WT(2008)Septic shock-vasopressin, norepinephrine, and urgency N Engl J Med 358 954-6
[3]
Lidicker J(2001)The pathogenesis of vasodilatory shock N Engl J Med 345 588-95
[4]
Clermond G(2001)Physiology of vasopressin relevant to management of septic shock Chest 120 989-1002
[5]
Carcillo J(2002)Beneficial effects of short-term vasopressin infusion during severe septic shock Anesthesiology 96 576-82
[6]
Pinsky MR(1999)Low-dose vasopressin in the treatment of vasodilatory septic shock J Trauma 47 699-703
[7]
Parrillo JE(2001)Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 1368-77
[8]
Landry DW(2008)Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 Crit Care Med 36 296-327
[9]
Oliver JA(2006)Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 34 1589-96
[10]
Holmes CL(undefined)undefined undefined undefined undefined-undefined